Since the FDA declared the Ozempic and Wegovy shortage resolved on February 21, 2025, pharmacies had to stop making compounded versions: State-licensed pharmacies stopped by April 22, 2025 Outsourcing facilities stopped by May 22, 2025 This leaves only the brand-name options available, but with the new pricing through Medicare and TrumpRx, access is actually better than it was with compounded versions for many patients
A recent study published in the New England Journal of Medicine found that Wegovy, made by Novo Nordisk, helped teens reduce their BMI by about 16% on average, better than the results in adults
The main catechin of green tea, (-)-epigallocatechin-3-gallate (EGCG), reduces bleomycin-induced DNA damage in human leucocytes
Discussion This study conducted a comparative analysis of adverse event occurrences for semaglutide under different administration routes by analyzing the data from the United States Food and Drug Administrations (FDA) Adverse Event Reporting System (FAERS)